Episode 23: A Between the Biotech Waves conversation with Jim Birchenough, Vice Chair of Wells Fargo Biopharmaceutical Inv Banking
Between the Biotech Waves
00:00
Is the Inflation Reduction Act Positive Negative in Your Mind?
I think the worst thing for biotech is uncertainty. And I think that provides some clarity and companies can adapt around it. You know, if you think about Europe as sort of a counterpoint to what happens when we put more restrictive pricing constraints on the drug industry, we still see biotech innovation and pricing holding up better than traditional pharma.
Transcript
Play full episode
